-
Product Insights
NewQuarterly Fortified Wine pricing trends in Australia
Empower your strategies with our Quarterly Fortified Wine pricing trends in Australia report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...
-
Product Insights
Maxwell Solar PV Park
Maxwell Solar PV Park is a solar PV project located in New South Wales, Australia. The project is owned by Malabar Resources Ltd and is developed by EDF Renewables SA. The project is at the permitting stage. Empower your strategies with our Maxwell Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
Maxwell Downs Solar PV Park
Maxwell Downs Solar PV Park is a solar PV project located in New South Wales, Australia. The project is owned and being developed by X-Elio Australia Pty Ltd. The project is at the permitting stage. Empower your strategies with our Maxwell Downs Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Company Insights
Innovation and Patenting activity of Suzhou Maxwell Technologies Co Ltd Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Suzhou Maxwell Technologies Co Ltd Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Product Insights
NewOtitis Media – Drugs In Development, 2024
Empower your strategies with our Otitis Media – Drugs In Development, 2024 report and make more profitable business decisions. Otitis media (OM) is any inflammation of the middle ear, the air-filled space behind the eardrum that contains the tiny vibrating bones of the ear. Symptoms include ear pain, difficulty sleeping, loss of balance, fever, headache, and loss of appetite. Risk factors include age, seasonal factors, and exposure to tobacco smoke or high levels of air pollution. Treatment includes antibiotics and antipyrine....
-
Product Insights
NewSinusitis – Drugs In Development, 2024
Empower your strategies with our Sinusitis – Drugs In Development, 2024 report and make more profitable business decisions. Sinusitis is characterized by inflammation of the sinuses. This inflammation usually stems from a viral or bacterial infection or from an allergy. Symptoms include congestion and obstruction in the nose, pain, tenderness, hyposmia, halitosis, cough, toothache, headache, and pain over the cheeks just below the eyes. Risk factors include asthma, nasal passage abnormality, immune system disorder such as HIV/AIDS or cystic fibrosis, and...
-
Product Insights
NewRhinosinusitis – Drugs In Development, 2024
Empower your strategies with our Rhinosinusitis – Drugs In Development, 2024 report and make more profitable business decisions. Rhinosinusitis is a condition that affects the nasal and sinus mucosa, causing inflammation and symptoms such as nasal congestion, discharge, pain, and loss of smell. It can be classified into acute or chronic, depending on the duration of the illness. Acute rhinosinusitis usually lasts less than four weeks and is often caused by viral or bacterial infections. Chronic rhinosinusitis lasts more than 12...
-
Product Insights
NewEbolavirus Infections (Ebola Hemorrhagic Fever) – Drugs In Development, 2024
Empower your strategies with our Ebolavirus Infections (Ebola Hemorrhagic Fever) – Drugs In Development, 2024 report and make more profitable business decisions. Ebola is a rare but deadly viral infection that causes bleeding inside and outside the body. Signs and symptoms include fever, severe headache, joint and muscle aches, sore throat, nausea and vomiting, diarrhea, chest pain, and cough. Supportive therapy includes oxygen therapy, blood transfusions, intravenous fluids, and pain relievers. The Ebolavirus Infections (Ebola Hemorrhagic Fever) drugs in development market...
-
Product Insights
NewMycoses – Drugs In Development, 2024
Empower your strategies with our Mycoses – Drugs In Development, 2024 report and make more profitable business decisions. Mycoses, also known as fungal infections, encompass a diverse group of diseases caused by fungi. These infections can affect various tissues in the body, including the skin, nails, and internal organs. Superficial mycoses, like athlete's foot and ringworm, involve the outer layers, while systemic mycoses can affect deeper tissues and may be more severe, particularly in individuals with weakened immune systems. Candidiasis is...
-
Thematic Analysis
Batteries – Thematic Intelligence
Explore the following trends and insights from the ‘Batteries’ thematic report: Synopsis of the batteries theme and understand its progress over the past decade. Key trends impacting the growth of the theme over the next 12 to 24 months, namely, technology trends, macroeconomic trends, and regulatory trends. Multiple data sets, including patents and M&A trends, to set smart business goals. The report also provides a timeline highlighting milestones in the development of the batteries. Core segments of the value chain, including...